The interaction between immune cells and tumour cells, particularly through ligand‒receptor pathways and the secretion of TGFβ, plays a crucial role in shaping the characteristics of different tumour foci and potentially influencing patient outcomes. Here, TGFB1 is linked to neoplasm.